Endocrinology

Top Story

Maternal serum prolactin associated with postpartum prediabetes, diabetes risk

Maternal serum prolactin associated with postpartum prediabetes, diabetes risk
April 29, 2016

Higher maternal serum prolactin in pregnancy is associated with improved pancreatic beta-cell function and lower risk for prediabetes or type 2 diabetes 3 months postpartum, recent study findings show.

“The measurement of serum prolactin in pregnancy may identify those women who are the highest risk for postpartum progression to prediabetes/diabetes,” Ravi Retnakaran, MD, MSc, FRCPC, an endocrinologist and clinician-scientist at the Leadership Sinai Centre for Diabetes and Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto, and associate professor, division of endocrinology, University of Toronto, told Endocrine Today. “As such, it might provide an approach for identifying those women in whom it is most important to ensure completion of the postpartum oral glucose tolerance test that is recommended in the first 6 months following a pregnancy complicated by gestational diabetes.”

In the Journals

Neighborhood deprivation increases type 2 diabetes risk

April 29, 2016
Refugees arriving in Sweden between 1987 and 1991 who resettled in more economically deprived neighborhoods were more likely to develop type 2 diabetes than those who…
In the Journals

Physicians who do not certify more likely to receive disciplinary actions

April 28, 2016
An analysis of data sets found that 95% of internal medicine residents achieve certification through the American Board of Internal Medicine, according to findings…
In the Journals

Prediabetes increases risk for chronic kidney disease

April 28, 2016
Patients with prediabetes are at modestly increased risk for developing chronic kidney disease, recent study findings show.In a systematic review, Justin B
In the Journals

Large variation in TSH reference limits seen during first trimester of pregnancy

April 28, 2016
During the first trimester of pregnancy, thyroid-stimulating hormone reference limits differ widely, according to recent findings. Frequent misclassification and…
More News Headlines »
CME CNE CPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Video
Meeting News Coverage

DMR System receives CE Mark for treatment of diabetes, NAFLD

Endocrine Today Europe Edition, May 2016
More »
Featured
Highlights from ENDO 2016

Highlights from ENDO 2016

CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan